2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland.
about
Cladribine with immediate rituximab for the treatment of patients with variant hairy cell leukemia.Hairy Cell Leukaemia in Oman: Four cases.Adenine: an important drug scaffold for the design of antiviral agentsHairy cell leukemia: clinicopathological and immunophenotypic study.Distinguishing hairy cell leukemia variant from hairy cell leukemia: development and validation of diagnostic criteria.
P2860
2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
2-chlorodeoxyadenosine (cladri ...... : 7-year experience in Poland.
@ast
2-chlorodeoxyadenosine (cladri ...... : 7-year experience in Poland.
@en
type
label
2-chlorodeoxyadenosine (cladri ...... : 7-year experience in Poland.
@ast
2-chlorodeoxyadenosine (cladri ...... : 7-year experience in Poland.
@en
prefLabel
2-chlorodeoxyadenosine (cladri ...... : 7-year experience in Poland.
@ast
2-chlorodeoxyadenosine (cladri ...... : 7-year experience in Poland.
@en
P2093
P1476
2-chlorodeoxyadenosine (cladri ...... t: 7-year experience in Poland
@en
P2093
A B Skotnicki
A Dmoszyńska
A Hellmann
B Zdziarska
I Urasiński
J Dwilewicz-Trojaczek
J Hołowiecki
K Hałaburda
P356
10.1111/J.1600-0609.1999.TB01114.X
P577
1999-01-01T00:00:00Z